Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
Jemal BeksisaTewodros GetinetSisay TanieJilcha Diribi FeyisaHamid Yimam HassenPublished in: PloS one (2020)
The overall 2-, 3- and 5-year survival of prostate cancer patients in Ethiopia is very low. The cancer stage at diagnosis and treatment modalities are significant prognostic determinants of survival. Therefore, early detection through screening and timely initiation of treatment are essential to improve the survival of prostate cancer patients.
Keyphrases
- prostate cancer
- end stage renal disease
- free survival
- radical prostatectomy
- healthcare
- chronic kidney disease
- ejection fraction
- newly diagnosed
- palliative care
- emergency department
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- young adults
- combination therapy
- patient reported outcomes
- electronic health record
- squamous cell